In the News
An inside look at a national, bilingual telemedicine service
Galileo is a telehealth service that delivers 24/7 primary and specialty care in both English and Spanish. It operates across all 50 U.S. states and enjoys support from regional and national health plans, Fortune 500 organizations, and employers of a variety of sizes. The fact that Galileo offers fully bilingual...
Augmedix Reports Second Quarter 2022 Financial Results
On August 8, 2022, Augmedix reported its financial results for the three-month period that ended on June 30, 2022. Manny Krakaris, chief executive officer of Augmedix, noted that “we continued to see good momentum and are pleased with our strong start to 2022. We remain focused on our path to profitability as we...
Augmedix Announces Expanded Partnership with Adventist Health
Augmedix has announced a groundbreaking partnership with Adventist Health. The data-driven partnership aims to utilize Adventist’s experience as a nonprofit health system integrated into more than 80 communities in the western United States. The partnership was reached as a piece of a scalable plan to aid physicians...
The Top 100 Healthcare Technology Companies of 2022
Augmedix has made the Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2022. “The awardees on this year’s list represent the absolute best in the healthcare technology space,” the Healthcare Technology Report wrote. “These companies are changing the face of the industry.” What all the...
C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research
Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, have announced a partnership that uses synthetic data to help researchers more easily develop drugs to treat rare diseases. Replica Analytics will help generate synthetic datasets across rare and orphan indications in which patient-level...
Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market
Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct investment, access to Azure Cloud computing, and...
McKesson Ventures Takes the ParityPledge to Commit to Increasing Representation for Women and People of Color
McKesson Ventures has signed the Parity.org ParityPledge® in Support of People of Color and in Support of Women. The ParityPledge simply asks that companies commit to interview and consider at least one qualified woman and person of color for every open role, VP and above, including the C-suite and the board of...
OncoHealth Secures Strategic Investments from Arsenal Capital Partners & McKesson Corporation
OncoHealth announced today that Arsenal Capital Partners and McKesson Corporation have strategically invested in the company. The funding, which gives Arsenal a majority ownership stake in OncoHealth, will help the company continue developing its oncology-focused digital health platform. John DiGiovanni, an...
AllyAlign, Partners Form Curana Health to Expand Value-Based Care in Senior Living
As value-based care continues to expand at a rapid pace within senior living, AllyAlign Health has announced a partnership with two different health care organizations. The partnership forms Curana Health, with the intention of helping skilled nursing and senior living facilities across the U.S. The three companies,...
Reimagine Care and University of Colorado Anschutz Medical Campus Collaborate to Provide Home-Centered Care to Bone Marrow Transplant Patients
Reimagine Care, a provider of technology-enabled services that support oncologists in delivering high-quality, home-centered, value-based cancer care, has collaborated with the University of Colorado Anschutz Medical Campus (CU Anschutz) to deliver care to bone marrow transplant patients. The collaboration will...
Press Releases
RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials
Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested...
Replica Analytics unveils Replica Synthesis 3.0
Replica Analytics, an Aetion company, has released Replica Synthesis 3.0, its privacy- and utility-preserving synthetic data generation software that has been updated with an enhanced user experience. This makes it easier for analysts to train generative models and...
M2GEN Rebrands to Aster Insights
Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for...
Reimagine Care and The Center for Cancer & Blood Disorders Announce Partnership
Reimagine Care announced that it has partnered with The Center for Cancer & Blood Disorders (CCBD), one of the country’s most respected cancer centers, to offer its home-based supportive care and symptom management program to patients in the Dallas-Fort Worth...
Modern Healthcare Recognizes IVX Health in its 2022 Best Places to Work in Healthcare List
For the fourth consecutive year, IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare in 2022. This annual program identifies and honors 150 outstanding companies and organizations in the healthcare industry nationwide,...